Documents
A list of downloadable documents created during development.
Breast cancer (advanced or metastatic) - lapatinib: second appeal
Breast cancer (advanced or metastatic) - lapatinib: final appraisal determination
-
Consultee and commentator comments on the ACD
Breast cancer (advanced or metastatic) - lapatinib: (2nd line) paper - post GE January 2010
Breast cancer (advanced or metastatic) - lapatinib: appraisal consultation document
-
Evaluation report
-
Non-manufacturer submissions
-
GlaxoSmithKline (including clarification required from NICE)
Breast cancer (advanced or metastatic) - lapatinib: appeal
Breast cancer (advanced or metastatic) - lapatinib: final appraisal determination
-
Response to consultee, commentator and public comments on the ACD and comments from website consultation
-
Consultee and commentator comments on the ACD
-
Expert comments on the ACD
Breast cancer (advanced or metastatic) - lapatinib (appraisal consultation 2)
-
Breast cancer (advanced or metastatic) - lapatinib: evaluation report
-
Non-manufacturer submissions
-
Manufacturer submission
-
Decision Support Unit report
Breast cancer (advanced or metastatic) - lapatinib (appraisal consultation)
-
Breast cancer (advanced or metastatic) - lapatinib: evaluation report
-
Breast cancer (advanced or metastatic) - lapatinib: Non-manufacturer submissions
-
Breakthrough Breast Cancer, Breast Cancer Campaign, Breast Cancer Care, and Cancerbackup (joint submission)
-
Expert written personal statements